Systemic Therapy for Hepatocellular Carcinoma: Current Updates and Outlook

Hepatocellular carcinoma (HCC) has emerged the culprit of cancer-related mortality worldwide with its dismal prognosis climbing. In recent years, ground-breaking progress has been made in systemic therapy for HCC. Targeted therapy based on specific signaling molecules, including sorafenib, lenvatini...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Yinjie, Xue, Hang, Zheng, Huachuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977221/
https://www.ncbi.nlm.nih.gov/pubmed/35388357
http://dx.doi.org/10.2147/JHC.S358082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977221/
https://www.ncbi.nlm.nih.gov/pubmed/35388357
http://dx.doi.org/10.2147/JHC.S358082

Ejemplares similares